- NOTE: This article is from 2012
This article explores current and potential future options for the treatment of BCCs.
Basal cell carcinoma is the most common malignancy found in humans. The incidence in Australia is the highest worldwide, at 1041 per 100,000 in men and 745 per 100,000 in women.1
Although the tumour can occur at any age, its incidence increases markedly in people over 40.
Eighty-five percent of all BCCs appear on the head and neck.2 BCCs are usually localised, slow-growing tumours that rarely